Bromodomain-containing protein 4 (BRD4), a key epigenetic regulator in TNBC, drives oncogene transcription and promotes tumor cell survival; however, the application of its inhibitor JQ1 (Figure 3) is often limited by drug resistance [64]. This evidence concerns the gene BRD4 and neoplasm.